首页> 外国专利> Combination preparation useful as antiviral agent effective against herpes viruses, especially herpes simplex, contains acetylsalicylic acid and 5-sulfonyl-2-phenylacetamido-thiazole derivative

Combination preparation useful as antiviral agent effective against herpes viruses, especially herpes simplex, contains acetylsalicylic acid and 5-sulfonyl-2-phenylacetamido-thiazole derivative

机译:可用作抗疱疹病毒,特别是单纯疱疹病毒的抗病毒剂的组合制剂,其中含有乙酰水杨酸和5-磺酰基-2-苯基乙酰氨基-噻唑衍生物

摘要

Combination preparation (A) contains: (a) acetylsalicylic acid (ASA) and (b) 5-aminosulfonyl-2-phenylacetamido-thiazole derivatives (I) or 5-halosulfonyl-2-phenylacetamido-thiazole derivatives (IV). Combination preparation (A) contains: (a) acetylsalicylic acid (ASA) and (b) thiazole derivatives of formula (I) (or their salts) or (IV). R1 = H, halo, alkyl, alkoxy, aminoalkyl or haloalkyl; R2, R3 = H, alkoxy, cycloalkyl or biphenylaminocarbonyl, alkyl (optionally substituted (os) by 1-3 of 3-6C cycloalkyl, alkoxy, halo, OH, NH2, trialkylsilyloxy, 3,4-methylenedioxyphenyl, tetrahydrofuran-2-yl, N(R2a)COOtBu, Het1, Het2 or aryl (os by OH or alkoxy)), P(O)(OR8)(OR9), COCH(NH2)-R10, CHR11-OCOR12 or CH(NH2)-R10, or NR2R3 = 5- or 6-membered saturated heterocyclyl, optionally containing a further O heteroatom; R2a, R8, R9 = H or 1-4C alkyl; Het1 = C- or N-bonded 5- or 6-membered aromatic heterocyclyl containing 1-3 of S, N and/or O as heteroatom(s); Het2 = C- or N-bonded 3-8 membered, saturated or unsaturated, non-aromatic heterocyclyl containing 1-3 of S, N and/or O as heteroatom(s); R10 = side-chain of a naturally occurring aminoacid; R11 = 1-4C alkyl; R12 = H, 1-4C alkyl or CH(NH2)-R10; R4 = H, acyl, 2-6C alkenyl or cycloalkyl, or alkyl (os by 1-3 of halo, OH, cycloalkyl, acyl, alkoxy, COOH, NHCOOtBu, OEt, CH2CH2OEt, phenoxy, aryl or NR13R14), or alkyl substituted by optionally benzo-fused Het1, 2-(R16)-pyrrolidino, tetrahydrofuran-2-yl, benzo-1,4-dioxan-2-yl, 2-oxo-pyrrolidino or OCOR17R18; R13, R14 = H, acyl, alkyl, CONH2, mono- or dialkylaminoalkyl, mono- or dialkylaminocarbonyl, aryl or alkoxycarbonyl, or NR13R14 = 5- or 6-membered saturated heterocyclyl, optionally containing a further O, S or NR15 heteroatom and os by =O; R15 = H or 1-4C alkyl; R16 = H or alkyl; R17, R18 = H, or alkyl or aryl (both os by 1-3 of OH, alkoxy or halo); R5, R7 = H, alkyl, halo, NH2, mono- or di-alkylamino or alkanoylamino; R6 = phenyl (os by 1-3 groups R6a); R6a = halo, aryl (os by 1-3 of alkanoyl, alkoxy, alkyl, halo, alkoxycarbonyl, NO2, haloalkyl, haloalkoxy, NH2, alkylthio, OH, COOH, CONH2, mono- or di-alkylaminocarbonyl, mono- or di-alkanoylamino, alkoxycarbonylamino, alkylsulfoxy, alkylsulfonyl, trialkylsilyloxy, Het2 or CN), alkoxy (os by 1-6 F, but not perfluorinated), alkoxycarbonyl, alkylthio, OH, COOH, alkyl (os by tetrahydrofuran-2-yl), Het1 (os by 1-3 of alkanoyl, alkoxy, alkyl, halo, alkoxycarbonyl, NO2, haloalkyl, haloalkoxy, NH2, alkylthio, OH, COOH, CONH2, mono- or dialkylaminocarbonyl, mono- or di-alkanoylamino, alkoxycarbonylamino, alkylsulfoxy, alkylsulfonyl, Het2 (mono- or bi-cyclic) or CN), Het2 (mono- or bi-cyclic; and os by 1-3 of =O, halo, OH, alkoxycarbonyl, alkoxycarbonylamino, alkyl, haloalkyl or hydroxyalkyl), 2-6C alkenyl, OR19, NR20R21, CONR22R23, carbazole, dibenzofuran, dibenzothiophene, xanthene or 9,10-dihydroacridine; R19 = phenyl (os by NR24R25) or alkyl (os by 1-3 of OH or halo); R24, R25 = H, alkyl or acyl; R20, R21 = H, CONH2, mono- or di-alkylaminocarbonyl, phenyl, acyl or alkyl (os by alkoxy or acyl, or by phenyl or Het1 (both os by 1-3 of halo or OH)); R22, R23 = H or alkyl, and D = halogen; Alkyl moieties or acyl groups have 1-6C, cycloalkyl moieties 3-8C and aryl moieties 6-10C unless specified otherwise.
机译:组合制剂(A)含有:(a)乙酰水杨酸(ASA)和(b)5-氨基磺酰基-2-苯基乙酰氨基-噻唑衍生物(I)或5-卤磺酰基-2-苯基乙酰氨基-噻唑衍生物(IV)。组合制剂(A)含有:(a)乙酰水杨酸(ASA)和(b)式(I)的噻唑衍生物(或其盐)或(IV)。 R1 = H,卤素,烷基,烷氧基,氨基烷基或卤代烷基; R 2,R 3 = H,烷氧基,环烷基或联苯基氨基羰基,烷基(任选地被3-6C环烷基中的1-3个环取代的(os),烷氧基,卤素,OH,NH 2,三烷基甲硅烷氧基,3,4-亚甲基二氧基苯基,四氢呋喃-2-基,N(R2a)COOtBu,Het1,Het2或芳基(通过OH或烷氧基生成的os),P(O)(OR8)(OR9),COCH(NH2)-R10,CHR11-OCOR12或CH(NH2)-R10,或NR 2 R 3 = 5或6元饱和杂环基,任选地含有另外的O杂原子;或R2a,R8,R9 = H或1-4C烷基; Het1 =含有1-3个S,N和/或O作为杂原子的C或N键结合的5或6元芳族杂环基; Het2 =含有1-3个S,N和/或O作为杂原子的C或N键合的3-8元饱和或不饱和非芳香族杂环基; R10 =天然存在的氨基酸的侧链; R11 = 1-4C烷基; R12 = H,1-4C烷基或CH(NH2)-R10; R4 = H,酰基,2-6C烯基或环烷基或烷基(由卤素,OH,环烷基,酰基,烷氧基,COOH,NHCOOOtBu,OEt,CH2CH2OEt,苯氧基,芳基或NR13R14的1-3取代)通过任选的苯并稠合的Het1、2-(R16)-吡咯烷酮,四氢呋喃-2-基,苯并-1,4-二恶烷-2-基,2-氧代吡咯烷酮或OCOR17R18; R 13,R 14 = H,酰基,烷基,CONH 2,单或二烷基氨基烷基,单或二烷基氨基羰基,芳基或烷氧基羰基,或NR 13 R 14 = 5或6元饱和杂环基,任选地包含另外的O,S或NR 15杂原子和os由= O; R15 = H或1-4C烷基; R16 = H或烷基; R17,R18 = H,或烷基或芳基(两者均为1-3,OH,烷氧基或卤素); R5,R7 = H,烷基,卤素,NH2,单或二烷基氨基或烷酰基氨基; R6 =苯基(由1-3个R6a基团组成的os); R 6a =卤素,芳基(由烷酰基,烷氧基,烷基,卤素,烷氧基羰基,NO 2,卤代烷基,卤代烷氧基,NH 2,烷硫基,OH,COOH,CONH 2组成的1-3),单或二烷基氨基羰基,单或二-烷酰基氨基,烷氧基羰基氨基,烷基亚磺氧基,烷基磺酰基,三烷基甲硅烷基氧基,Het2或CN),烷氧基(在1-6 F下为os,但未全氟化),烷氧基羰基,烷硫基,OH,COOH,烷基(在四氢呋喃-2-yl上os) 1-3被烷酰基,烷氧基,烷基,卤代,烷氧基羰基,NO 2,卤代烷基,卤代烷氧基,NH 2,烷硫基,OH,COOH,CONH 2,单或二烷氨基羰基,单或二烷酰基氨基,烷氧基羰基氨基,烷基磺氧基,烷基磺酰基Het2(单环或双环)或CN),Het2(单环或双环;以及os = 1-3的= O,卤素,OH,烷氧羰基,烷氧羰基氨基,烷基,卤代烷基或羟烷基),2-6C烯基,OR19,NR20R21,CONR22R23,咔唑,二苯并呋喃,二苯并噻吩、,吨或9,10-二氢ac啶; R19 =苯基(NR24R25为os)或烷基(OH或卤素为1-3的os); R24,R25 = H,烷基或酰基; R20,R21 = H,CONH2,单或二烷基氨基羰基,苯基,酰基或烷基(通过烷氧基或酰基,或通过苯基或Het1(两者都被卤素或OH的1-3所取代)); R22,R23 = H或烷基,D =卤素;除非另有说明,否则烷基部分或酰基具有1-6C,环烷基部分3-8C和芳基部分6-10C。

著录项

  • 公开/公告号DE10129716A1

    专利类型

  • 公开/公告日2003-01-02

    原文格式PDF

  • 申请/专利权人 BAYER AG;

    申请/专利号DE2001129716

  • 申请日2001-06-22

  • 分类号A61K31/60;A61K31/426;

  • 国家 DE

  • 入库时间 2022-08-21 23:42:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号